All Stories

  1. Acetylcholinesterase Inhibitory Potential and ADMET Analysis and Molecular Docking Studies of Coumarin and Benzohydrazide Derivatives in Alzheimer’s Disease
  2. Exploring Mechanistic Insights by Carotenoids in Neuropathic and Inflammatory Pain
  3. Unlocking the therapeutic potential of Solanum species as alternatives for pain and inflammation management
  4. Design, Synthesis, SwissADME Profile DFT Studies, in vitro and in silico Anti-diabetic Potential of Novel Amide Derivatives Based on Bis((4-amino-4-oxobutanoyl)oxy) Zinc Scaffold
  5. Exploring Anticholinergic and anti-amnesic potential of methyl substituted monocarbonyl curcumin derivatives
  6. Studies on racemic triglycerides as urease enzyme inhibitors
  7. Exploring In Vivo Anti-Diabetic Potential of 2,3 and 2,6-dichloroindolinone: Biochemical and Histological Evidences
  8. Halogenated Curcumin Derivatives: SwissADME/ADMT, DFT and Biological Targets Prediction
  9. Optimization of Lavender Essential Oil and Phenolic Yield: Advances in Extraction, Metabolomics, and Functional Benefits
  10. Comprehensive in vivo Antidiabetic Investigations and antioxidant potential of Caralluma edulis whole Plant
  11. Inhibition of Calcium Oxalate Crystal Growth in Gel by Macrotyloma uniflorum, Phaseolus lunatus, and Phaseolus vulgaris
  12. Integrating in vitro and in silico approaches for exploring antidiabetic potential of dimethyl and thiomethyl indolinone derivatives
  13. Exploring the in vitro anti-diabetic potential and in silico studies of 2, 3 and 2, 6-dichloroIndolinone
  14. Preclinical and in silico studies of 3-benzothioyl-1-(3-hydroxy-3-phenyl-3-propyl)-1-methylthiourea: A promising agent for depression and anxiety
  15. Correction: Ullah et al. Natural Polyphenols for the Preservation of Meat and Dairy Products. Molecules 2022, 27, 1906
  16. Oxyresveratrol reduces lipopolysaccharide-induced inflammation and oxidative stress through inactivation of MAPK and NF-κB signaling in brain endothelial cells
  17. The most recent advances in liquisolid technology: Perspectives in the pharmaceutical industry
  18. Theaflavins Applications to Ameliorate Implant Failure and Eradicate Microbial Infections and Foodborne Pathogens: A Comprehensive Review
  19. Unlocking daidzein's healing power: Present applications and future possibilities in phytomedicine
  20. Paroxetine Loaded Nanostructured Lipid Carriers Based In-situ Gel for Brain Delivery via Nasal Route for Enhanced Anti-Depressant Effect: In Vitro Prospect and In Vivo Efficacy
  21. In vitro 5-LOX inhibitory and antioxidant potential of isoxazole derivatives
  22. Synergistic berberine chloride and Curcumin-Loaded nanofiber therapies against Methicillin-Resistant Staphylococcus aureus Infection: Augmented immune and inflammatory responses in zebrafish wound healing
  23. Defining the mechanisms behind the hepatoprotective properties of curcumin
  24. Vigna mungo (Linn.) Hepper: ethnobotanical, pharmacological, phytochemical, and nutritious profile
  25. Exploiting new strategies in combating head and neck carcinoma: A comprehensive review on phytochemical approaches passing through PI3K/Akt/mTOR signaling pathway
  26. Advancements in steroidal Pt(II) & Pt(IV) derivatives for targeted chemotherapy (2000–2023)
  27. Multitarget Mechanisms of Monocarbonyl Curcuminoid Analogues against HL-60 Cancer Cells: In Vitro and Network Pharmacology-Based Approach
  28. Mitigation of sciatica injury-induced neuropathic pain through active metabolites derived from medicinal plants
  29. Insight into Bioactive Compounds, Antioxidant and Anti-Diabetic Properties of Rosehip (Rosa canina L.)-Based Tisanes with Addition of Hibiscus Flowers (Hibiscus sabdariffa L.) and Saffron (Crocus sativus L.)
  30. In Silico, SwissADME, and DFT Studies of Newly Synthesized Oxindole Derivatives Followed by Antioxidant Studies
  31. Exploring the therapeutic potential of edible Pleurotus mushroom species for oxidative stress and diabetes management
  32. How gallic acid regulates molecular signaling: role in cancer drug resistance
  33. Use of Elicitors and Beneficial Bacteria to Induce and Prime the Stilbene Phytoalexin Response: Applications to Grapevine Disease Resistance
  34. Use of Elicitors and Beneficial Bacteria to Induce and Prime the Stilbene Phytoalexin Response: Main Experiments and Appli-cations to Grapevine Disease Resistance
  35. Administration of α-lipoic acid and silymarin attenuates aggression by modulating endocrine, oxidative stress and inflammatory pathways in mice
  36. Amentoflavone derivatives against SARS-CoV-2 main protease (MPRO): An in silico study
  37. Mentha longifolia Essential Oil and Pulegone in Edible Coatings of Alginate and Chitosan: Effects on Pathogenic Bacteria in Lactic Cheese
  38. Therapeutic potential of marine peptides in malignant melanoma
  39. Physicochemical properties, drug likeness, ADMET, DFT studies, and in vitro antioxidant activity of oxindole derivatives
  40. Pathophysiology of Gastrointestinal Tract Cancers and Therapeutic Status
  41. Glycosides in the Treatment of Gastrointestinal Tract Cancer
  42. Flavonoids in the Treatment of Gastrointestinal Tract Cancer
  43. Phytonutrients in the Treatment of Gastrointestinal Cancer
  44. Marine Cyanobacterial Peptides in Neuroblastoma: Search for Better Therapeutic Options
  45. The Exosome-Mediated PI3K/Akt/mTOR Signaling Pathway in Neurological Diseases
  46. Resveratrol regulates inflammation and improves oxidative stress via Nrf2 signaling pathway: Therapeutic and biotechnological prospects
  47. The regulatory role of non-coding RNAs and their interactions with phytochemicals in neurodegenerative diseases: a systematic review
  48. Synthesis, Characterization, and Pharmacokinetic Studies of Thiazolidine-2,4-Dione Derivatives
  49. Molecular Aspects and Therapeutic Implications of Herbal Compounds Targeting Different Types of Cancer
  50. Production of high molecular-ordered stilbene oligomers for the study of their biological activity: total synthesis, bio-catalyzed synthesis and production by plant systems
  51. Recent Advances in Genomics-Based Approaches for the Development of Intracellular Bacterial Pathogen Vaccines
  52. Multifaceted Pharmacological Potentials of Curcumin, Genistein, and Tanshinone IIA through Proteomic Approaches: An In-Depth Review
  53. Regulatory Effects of Curcumin on Platelets: An Update and Future Directions
  54. Citri Reticulatae Pericarpium (Chenpi) Protects against Endothelial Dysfunction and Vascular Inflammation in Diabetic Rats
  55. Uncovering the Anticancer Potential of Polydatin: A Mechanistic Insight
  56. Modulation of integrin receptor by polyphenols: Downstream Nrf2-Keap1/ARE and associated cross-talk mediators in cardiovascular diseases
  57. An insight in Salmonella typhi associated autoimmunity candidates' prediction by molecular mimicry
  58. Strategic Approaches to Target the Enzymes using Natural Compounds for the Management of Alzheimer’s Disease: A Review
  59. In-vivo anti-nociceptive activities of schiff bases aldehyde derivatives of 4-aminoantipyrine and their molecular docking studies
  60. Neuroblastoma: Essential genetic pathways and current therapeutic options
  61. The Therapeutic Potential of Kaemferol and Other Naturally Occurring Polyphenols Might Be Modulated by Nrf2-ARE Signaling Pathway: Current Status and Future Direction
  62. Flavonoids Targeting the mTOR Signaling Cascades in Cancer: A Potential Crosstalk in Anti-Breast Cancer Therapy
  63. Plants with Therapeutic Potential for Ischemic Acute Kidney Injury: A Systematic Review
  64. The Role of NRF2/KEAP1 Pathway in Glioblastoma: Pharmacological Implications
  65. Therapeutic Role of Carotenoids in Blood Cancer: Mechanistic Insights and Therapeutic Potential
  66. Phytochemicals Targeting Oxidative Stress, Interconnected Neuroinflammatory, and Neuroapoptotic Pathways Following Radiation
  67. Bioactive compounds: a goldmine for defining new strategies against pathogenic bacterial biofilms?
  68. Effects of Natural Products on Neuromuscular Junction
  69. Antimicrobial Potential of Curcumin: Therapeutic Potential and Challenges to Clinical Applications
  70. A new perspective on the treatment of Alzheimer's disease and sleep deprivation-related conse-quences: Curcumin
  71. Alkaloids and Colon Cancer: Molecular Mechanisms and Therapeutic Implications for Cell Cycle Arrest
  72. Anti-nociceptive and anti-inflammatory activities of the essential oil isolated from Cupressus arizonica Greene fruits
  73. A New Perspective on the Treatment of Alzheimer’s Disease and Sleep Deprivation‐Related Consequences: Can Curcumin Help?
  74. Effects of Polyphenols on Oxidative Stress, Inflammation, and Interconnected Pathways during Spinal Cord Injury
  75. Herbal Ingredients in the Prevention of Breast Cancer: Comprehensive Review of Potential Molecular Targets and Role of Natural Products
  76. Therapeutic potential of marine peptides in cervical and ovarian cancers
  77. Inhibitory effects of plant extracts and in Silico screening of the bioactive compounds against α-glucosidase
  78. Genome-wide Core Proteome Analysis of Brucella melitensis Strains for Potential Drug Target Prediction
  79. Modulating Gut Microbiota: An Emerging Approach in the Prevention and Treatment of Multiple Sclerosis
  80. Neuroprotective Effects of Ellagic Acid in Alzheimer's Disease: Focus on Underlying Molecular Mechanisms of Therapeutic Potential
  81. Bcl-2 Modulation in p53 Signaling Pathway by Flavonoids: A Potential Strategy towards the Treatment of Cancer
  82. Current Status and Future Perspectives on Therapeutic Potential of Apigenin: Focus on Metabolic-Syndrome-Dependent Organ Dysfunction
  83. Pain Perception and Management: Where do We Stand?
  84. Antinociceptive and Anti-Inflammatory Like Effects of Berberis baluchistanica
  85. Herbal Drug Interaction: Mechanistic Details through Pharmacokinetic Portfolio
  86. Detection, Treatment Planning, and Genetic Predisposition of Bruxism: A Systematic Mapping Process and Network Visualization Technique
  87. To combat covid naturally
  88. Curcumin–cisplatin chemotherapy: A novel strategy in promoting chemotherapy efficacy and reducing side effects
  89. Intrathecal Administration of Melatonin Ameliorates the Neuroinflammation- Mediated Sensory and Motor Dysfunction in A Rat Model of Compression Spinal Cord Injury
  90. Review on Green Synthesis of Silver Nanoparticles through Plants
  91. Therapeutic and Mechanistic Effects of Curcumin in Huntington’s Disease
  92. In Vivo and In Silico Studies of Flavonoids Isolated from Pistacia integerrima as Potential Antidiarrheal Agents
  93. Angiogenesis-related non-coding RNAs and gastrointestinal cancer
  94. Flavonoids modulate AMPK/PGC-1α and interconnected pathways toward potential neuroprotective activities
  95. Luteolin and cancer metastasis suppression: focus on the role of epithelial to mesenchymal transition
  96. Elucidating Role of Reactive Oxygen Species (ROS) in Cisplatin Chemotherapy: A Focus on Molecular Pathways and Possible Therapeutic Strategies
  97. Vegetable Extracts and Nutrients Useful in the Recovery from Helicobacter pylori Infection: A Systematic Review on Clinical Trials
  98. Effect of Chlorella vulgaris on Liver Function Biomarkers: a Systematic Review and Meta-Analysis
  99. Toxicity and bioaccumulation of manganese and chromium in different organs of common carp (Cyprinus carpio) fish
  100. Fagonia indica; A Review on Chemical Constituents, Traditional Uses and Pharmacological Activities
  101. Flavonoids targeting NRF2 in neurodegenerative disorders
  102. Astaxanthin targets PI3K/Akt signaling pathway toward potential therapeutic applications
  103. The Molecular Docking of Flavonoids Isolated from Daucus carota as a Dual Inhibitor of MDM2 and MDMX
  104. Insomnia
  105. Targeting apoptosis and autophagy following spinal cord injury: Therapeutic approaches to polyphenols and candidate phytochemicals
  106. Kaempferol as a Dietary Anti-Inflammatory Agent: Current Therapeutic Standing
  107. Autophagy-related MicroRNAs in chronic lung diseases and lung cancer
  108. A Pivotal Role of the Nrf2 Signaling Pathway in Spinal Cord Injury: A Prospective Therapeutics Study
  109. Critical Review on the Presence of Phthalates in Food and Evidence of Their Biological Impact
  110. Vaccine Design from the Ensemble of Surface Glycoprotein Epitopes of SARS-CoV-2: An Immunoinformatics Approach
  111. Therapeutic potential of alkaloids in autoimmune diseases: Promising candidates for clinical trials
  112. Targeting epigenetics in cancer: therapeutic potential of flavonoids
  113. Datura metel; A Review on Chemical Constituents, traditional Uses and Pharmacological Activities
  114. In Vitro α-glucosidase Inhibition and Computational Studies of Kaempferol Derivatives from Dryopteris cycanida
  115. Virtual Screening of Natural Products against Type II Transmembrane Serine Protease (TMPRSS2), the Priming Agent of Coronavirus 2 (SARS-CoV-2)
  116. Astaxanthin anticancer effects are mediated through multiple molecular mechanisms: A systematic review
  117. Antiurolithiatic effects of pentacyclic triterpenes: The distance traveled from therapeutic aspects
  118. Roles of Medicinal Plants and Constituents in Gynecological Cancer Therapy: Current Literature and Future Directions
  119. Effect of Sorbus domestica and its active constituents in an experimental model of colitis rats induced by acetic acid
  120. Lophenol and lathosterol from resin of Commiphora kua possess hepatoprotective effects in vivo
  121. Sedative, Muscle Relaxant-Like Effects, and Molecular Docking Study of Compounds Isolated from Salvia leriifolia
  122. Role of Dietary Antioxidants in Neurodegenerative Diseases: Where are We Standing?
  123. Antidepressant Potential of Lotus corniculatus L. subsp. corniculatus: An Ethnobotany Based Approach
  124. Resveratrol in Autism Spectrum Disorders: Behavioral and Molecular Effects
  125. Phytopharmacology and Clinical Updates of Berberis Species Against Diabetes and Other Metabolic Diseases
  126. The analgesic potential of glycosides derived from medicinal plants
  127. Relationship of Wine Consumption with Alzheimer’s Disease
  128. Oral microbiota and Alzheimer’s disease: Do all roads lead to Rome?
  129. Neuroprotective Effects of Quercetin in Alzheimer’s Disease
  130. In-silico Subtractive Proteomic Analysis Approach for Therapeutic Targets in MDR Salmonella enterica subsp. enterica serovar Typhi str. CT18
  131. Mechanics insights of curcumin in myocardial ischemia: Where are we standing?
  132. Glyco-nanoparticles: New drug delivery systems in cancer therapy
  133. Loading AKBA on surface of silver nanoparticles to improve their sedative-hypnotic and anti-inflammatory efficacies
  134. Targeting Inflammation by Flavonoids: Novel Therapeutic Strategy for Metabolic Disorders
  135. Therapeutic potential of naringin in neurological disorders
  136. Molecular Docking of Isolated Alkaloids for Possible α-Glucosidase Inhibition
  137. Targeting NF-κB signaling pathway in cancer by dietary polyphenols
  138. Computational Study of Natural Compounds for the Clearance of Amyloid-Βeta: A Potential Therapeutic Management Strategy for Alzheimer’s Disease
  139. MicroRNA targeting by quercetin in cancer treatment and chemoprotection
  140. A Multi-Biochemical and In Silico Study on Anti-Enzymatic Actions of Pyroglutamic Acid against PDE-5, ACE, and Urease Using Various Analytical Techniques: Unexplored Pharmacological Properties and Cytotoxicity Evaluation
  141. Pharmacophore studies of 1, 3, 4-oxadiazole nucleus: Lead compounds as α-glucosidase inhibitors
  142. Glycosides from Medicinal Plants as Potential Anticancer Agents: Emerging Trends Towards Future Drugs
  143. Flavonoids nanoparticles in cancer: Treatment, prevention and clinical prospects
  144. Polyphenols in the treatment of autoimmune diseases
  145. Kaempferol: A Key Emphasis to Its Anticancer Potential
  146. Plant-derived Glycosides with α-Glucosidase Inhibitory Activity: Current Standing and Future Prospects
  147. Apoptosis induced by luteolin in breast cancer: Mechanistic and therapeutic perspectives
  148. Bioactive peptides and proteins as alternative antiplatelet drugs
  149. Anti-cancer effects of polyphenols via targeting p53 signaling pathway: updates and future directions
  150. Antimicrobial and Antioxidant Potential of Berberisinol, a New Flavone from Berberis baluchistanica
  151. Targeting STATs in neuroinflammation: The road less traveled!
  152. Pharmacological basis for sedative and hypnotic like effects of Pyrus pashia using in vivo experimental models
  153. Biofunctional Beverage: Antihyperglycemic Effect of Green Tea in Alloxan Induced Diabetic Rabbits
  154. The role of flavonoids in autoimmune diseases: Therapeutic updates
  155. Mechanistic insights of hepatoprotective effects of curcumin: Therapeutic updates and future prospects
  156. Potent in Vitro α-Glucosidase Inhibition of Secondary Metabolites Derived from Dryopteris cycadina
  157. Genus Vanda: A review on traditional uses, bioactive chemical constituents and pharmacological activities
  158. Role of vitamin D and vitamin D receptor (VDR) in oral cancer
  159. Muscle relaxant activities of pistagremic acid isolated from Pistacia integerrima
  160. Targeting ubiquitin-proteasome pathway by natural, in particular polyphenols, anticancer agents: Lessons learned from clinical trials
  161. The mechanistic insight of polyphenols in calcium oxalate urolithiasis mitigation
  162. Antiplatelet Potential of Plant-Derived Glycosides as Possible Lead Compounds
  163. Molecular modeling studies of coruscanone (A) core nucleus as potential antifungal agents
  164. Current standing of plant derived flavonoids as an antidepressant
  165. Evidence and prospective of plant derived flavonoids as antiplatelet agents: Strong candidates to be drugs of future
  166. Evaluation of In-vitro Antimicrobial Potential of Daphne retusa Hemsl. Against Human Pathogenic Bacteria and Fungi
  167. Nephroprotective effect of Berberis baluchistanica against gentamicin-induced nephrotoxicity in rabbit
  168. Pharmacological and Therapeutic potential of Nitidine, a plant alkaloid
  169. Anti-inflammatory effects of Melatonin: a mechanistic review
  170. Flavonoids as acetylcholinesterase inhibitors: Current therapeutic standing and future prospects
  171. Anti-Parkinson Potential of Silymarin: Mechanistic Insight and Therapeutic Standing
  172. Antidepressant Potential of Peptides: New Insights as Future Therapeutic
  173. In-silico Studies of Isolated Phytoalkaloid Against Lipoxygenase: Study Based on Possible Correlation
  174. Isolation and Characterization of Two New Secondary Metabolites From Quercus incana and Their Antidepressant- and Anxiolytic-Like Potential
  175. Sedative and antinociceptive activities of two new sesquiterpenes isolated from Ricinus communis
  176. Targeting BDNF modulation by plant glycosides as a novel therapeutic strategy in the treatment of depression
  177. Apigenin as neuroprotective agent: Of mice and men
  178. Phyto-glycosides as Therapeutic Target in the Treatment of Diabetes
  179. Natural Products as an Emerging Therapeutic Alternative in the Treatment of Neurological Disorders
  180. An Overview on Citrus aurantium L.: Its Functions as Food Ingredient and Therapeutic Agent
  181. Anti-diabetic potential of peptides: Future prospects as therapeutic agents
  182. The relevance of folkloric usage of plant galls as medicines: Finding the scientific rationale
  183. Pharmacological and Toxicological Profile of Harmane-β-Carboline Alkaloid: Friend or Foe
  184. Pharmacological validation of the anxiolytic, muscle relaxant and sedative like activities of Capsicum annuum in animal model
  185. Plant-derived mPGES-1 inhibitors or suppressors: A new emerging trend in the search for small molecules to combat inflammation
  186. Potential health benefits of natural products derived from truffles: A review
  187. Antifungal Potential of Alkaloids As An Emerging Therapeutic Target
  188. Therapeutic potential of songorine, a diterpenoid alkaloid of the genus Aconitum
  189. Renin-angiotensin-aldosterone (RAAS): The ubiquitous system for homeostasis and pathologies
  190. Fatty Acid Composition and Biological Activities of Oily Fractions from Pistacia integerrima Roots
  191. Sedative and muscle relaxant activities of diterpenoids from Phlomidoschema parviflorum
  192. Bioassay-Guided Isolation of Antioxidants from Diospyros lotus Roots
  193. Plant bioactive molecules bearing glycosides as lead compounds for the treatment of fungal infection: A review
  194. A Comprehensive Review on Ebola (EBOV) Virus: Future Prospects
  195. A holistic review on the autoimmune disease vitiligo with emphasis on the causal factors
  196. Antidepressent Effect of Two New Benzyl Derivatives from Wild Strawberry Fragaria vesca var. nubicola Lindl. ex Hook.f.
  197. Gastrointestinal Motility and Acute Toxicity of Pistagremic Acid Isolated from the Galls of Pistacia integerrima
  198. Advances in Antioxidant Potential of Natural Alkaloids
  199. Sedative-hypnotic-like effect and molecular docking of di-naphthodiospyrol from Diospyros lotus in an animal model
  200. Glycosides as Possible Lead Antimalarial in New Drug Discovery: Future Perspectives
  201. Potential of Plant Alkaloids as Antipyretic Drugs of Future
  202. In vivo and in silico sedative-hypnotic like activity of 7-methyljuglone isolated from Diospyros lotus L.
  203. Therapeutic potential of Alkaloids as anti-bacterial agents: Drugs of future
  204. ACE Inhibition of Plant Alkaloids Targeted Approach for Selective Inhibition
  205. Fabrication of Tamarindus indica seeds extract loaded-cream for photo-aged skin: Visioscan® studies
  206. Mechanisms Underlying Anti-hyperalgesic Properties of Kaempferol-3,7- di-O-α-L-rhamnopyranoside Isolated from Dryopteris cycadina
  207. Elucidation of Phosphodiesterase-1 Inhibitory Effect of Some Selected Natural Polyphenolics Using In Vitro and In Silico Methods
  208. Anti-inflammatory Potential of Alkaloids as a Promising Therapeutic Modality
  209. Antimicrobial and antioxidant activities of a new metabolite from Quercus incana
  210. In Silico Study of Alkaloids as α-Glucosidase Inhibitors: Hope for the Discovery of Effective Lead Compounds
  211. Anti-cancer Potential of Phyto-alkaloids: A Prospective Review
  212. Plant Alkaloids as Antiplatelet Agent: Drugs of the Future in the Light of Recent Developments
  213. Antinociceptive and anti-inflammatory properties of methanol fruit extract of Quercus incana in rat and mice models
  214. Alkaloids: An Emerging Antibacterial Modality Against Methicillin Resistant Staphylococcus aureus
  215. Effects of Nigella sativa (Kalonji) and Honey on Lipid Profile of Hyper lipidemic Smokers
  216. Revival of Natural Products: Utilization of Modern Technologies
  217. Antinociceptive and anti-inflammatory activities of flavonoids isolated from Pistacia integerrima galls
  218. Plant Alkaloids as an Emerging Therapeutic Alternative for the Treatment of Depression
  219. Emerging CAM Ziziphus nummularia with in vivo sedative-hypnotic, antipyretic and analgesic attributes
  220. Evidence Based Alternative Medicines in Pain Management
  221. Biological Evaluation and Docking Analysis of Daturaolone as Potential Cyclooxygenase Inhibitor
  222. POM Analysis of Phytotoxic Agents from Pistacia integerrima Stewart
  223. Formulation and in-vitro evaluation of directly compressed controlled release matrices of Losartan Potassium using Ethocel Grade 100 as rate retarding agent
  224. Pharmacological basis for the use of Hypericum oblongifolium as a medicinal plant in the management of pain, inflammation and pyrexia
  225. Isolation and characterization of two new diterpenoids from Stachys parviflora: Antidiarrheal potential in mice
  226. Urease inhibitory profile of extracts and chemical constituents ofPistacia atlanticassp. cabulica Stocks
  227. Medicinal plants with anti-inflammatory activities
  228. Biofunctional properties ofEruca sativaMiller (rocket salad) hydroalcoholic extract
  229. Anti-tumour-promoting and thermal-induced protein denaturation inhibitory activities of β-sitosterol and lupeol isolated fromDiospyros lotusL.
  230. Suppression of inflammatory response by chrysin, a flavone isolated from Potentilla evestita Th. Wolf. In silico predictive study on its mechanistic effect
  231. Characterization and antinociceptive activity (in vivo) of kempferol-3,4′-di-O-α-L-rhamnopyranoside isolated from Dryopteris cycadina
  232. Cytotoxic and phytotoxic actions ofHeliotropium strigosum
  233. In vivo sedative and muscle relaxants activity of Diospyros lotus L
  234. Inhibition on Urease and Thermal Induced Protein Denaturation of commonly used Antiulcer Herbal Products. Study based on in-vitro assays
  235. Bioassay-guided isolation of antibacterial constituents fromDiospyros lotusroots
  236. Inhibition of thermal induced protein denaturation of extract/fractions of Withania somnifera and isolated withanolides
  237. Anti-hyperalgesic activity of crude extract and 7-methyljuglone ofDiospyros lotusroots
  238. Cytotoxic, antitumour-promoting and inhibition of protein denaturation effects of flavonoids, isolated fromPotentilla evestitaTh. Wolf
  239. Antimicrobial and inhibition on heat-induced protein denaturation of constituents isolated fromPolygonatumverticillatumrhizomes
  240. Patho-Phyisology of Urease: Urease Inhibiters as a Significant Therapeutic Goal
  241. Therapeutic Potential of Alkaloids in Cough Treatment
  242. Evidence Based Alternative Medicines in Pain Management
  243. Phosphodiesterase-1 Inhibitory Activity of Two Flavonoids Isolated fromPistacia integerrimaJ. L. Stewart Galls
  244. Antinociceptive and anti-inflammatory potential of Rhododendron arboreum bark
  245. Antipyretic and antinociceptive potential of extract/fractions of Potentilla evestita and its isolated compound, acacetin
  246. In-vivo antinociceptive, anti-inflammatory and antipyretic activity of pistagremic acid isolated from Pistacia integerrima
  247. In Vitro Attenuation of Thermal-Induced Protein Denaturation by Aerial Parts of Artemisia scoparia
  248. First evidence of the analgesic activity of govaniadine, an alkaloid isolated fromCorydalis govanianaWall.
  249. Coordination of Silver Sulfadiazine with Glutathione in Aqueous Medium
  250. Medicinal Plants in Light of History
  251. Antipyretic and antinociceptive activity of Diospyros lotus L. in animals
  252. The Effect of Extract/Fractions of Caralluma tuberculata on Blood Glucose Levels and Body Weight in Alloxan-Induced Diabetic Rabbits
  253. In vivoantinociceptive and anti-inflammatory activities of umbelliferone isolated fromPotentilla evestita
  254. Antiulcer Effect of Extract/Fractions of Eruca sativa: Attenuation of Urease Activity
  255. Antipyretic Activity of Decoction of Joshanda and Its Saponin and Sterol Contents
  256. Medicinal Plants Need Biological Screening: A Future Treasure as Therapeutic Agents
  257. Clinical Updates on Substance-P Antagonist in Pain Management
  258. The Biological Performance of Crataegus songarica Against Certain Infectious Fungal and Bacterial Diseases
  259. In vivo antinociceptive and anticonvulsant activity of extracts of Heliotropium strigosum
  260. Phytochemical analysis, antibacterial, and antifungal assessment of aerial parts of Polygonatumverticillatum
  261. Antinociceptive activity of cyclopeptide alkaloids isolated from Ziziphus oxyphylla Edgew (Rhamnaceae)
  262. Development, characterization and antioxidant activity of polysorbate based O/W emulsion containing polyphenols derived from Hippophae rhamnoides and Cassia fistula
  263. Antispasmodic and antidiarrheal activities of rhizomes of Polygonatum verticillatum maneuvered predominately through activation of K+ channels
  264. Withanolides isolated from Withania somnifera with α-glucosidase inhibition
  265. Antioxidant profile of constituents isolated from Polygonatumverticillatum rhizomes
  266. Studies on tracheorelaxant and anti-inflammatory activities of rhizomes of Polygonatum verticillatum
  267. Anti-inflammatory activity of Heliotropiumstrigosum in animal models
  268. Attenuation of erythrocytic actylcholinesterase by antidepressants
  269. Lipoxygenase and urease inhibition of the aerial parts of the Polygonatum verticillatum
  270. Antipyretic and anticonvulsant activity of n-hexane fraction of Viola betonicifolia
  271. Prokinetic and laxative effects of the crude methanolic extract of Viola betonicifolia whole plant in rodents
  272. In vivo screening of essential oils of Skimmia laureola leaves for antinociceptive and antipyretic activity
  273. Analgesic and Anti-inflammatory Profile of n-Hexane Fraction of Viola betonicifolia
  274. Muscle Relaxant and Sedative-Hypnotic Activities of Extract ofViola betonicifoliain Animal Models Supported by Its Isolated Compound, 4-Hydroxy Coumarin
  275. Antibacterial, antioxidant and cytotoxic studies of total saponin, alkaloid and sterols contents of decoction of Joshanda
  276. Bronchodilator Activity of Aerial Parts ofPolygonatum verticillatumAugmented by Anti-inflammatory Activity: Attenuation of Ca2+Channels and Lipoxygenase
  277. Isolation of long-chain esters from the rhizome of Polygonatum verticillatum by potent tyrosinase inhibition
  278. Isolation of a new bioactive cinnamic acid derivative from the whole plant of Viola betonicifolia
  279. Antipyretic and Anticonvulsant Activity of Polygonatum verticillatum : Comparison of Rhizomes and Aerial Parts
  280. Evaluation of n-hexane extract of Viola betonicifolia for its neuropharmacological properties
  281. Antimalarial and free radical scavenging activities of rhizomes of Polygonatum verticillatum supported by isolated metabolites
  282. Polygonatum verticillatum All.